{"id":"W4390021910","doi":"10.1016/s2352-3026(23)00338-1","title":"Oral decitabine–cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study","year":2023,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"ca_institutions":"Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Hôpital Maisonneuve-Rosemont; University of Alberta; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Ottawa Hospital; University of Ottawa","funders":"Astex Pharmaceuticals","keywords":"Decitabine; Medicine; Chronic myelomonocytic leukemia; Myelodysplastic syndromes; Azacitidine; Internal medicine; International Prognostic Scoring System; Adverse effect; Oncology; Pharmacology; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001582197,0.001903676,0.003738996,0.000566208,0.000442448,0.001282686,0.001053198,0.001756725,0.006481716],"category_scores_gemma":[0.001821391,0.0009719372,0.00200532,0.0006064386,0.001705555,0.001400825,0.000496942,0.003355192,0.001252229],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009135816,"about_ca_system_score_gemma":0.001055905,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001351943,"about_ca_topic_score_gemma":0.002748664,"domain_scores_codex":[0.9992204,0.0004190313,0.00003703279,0.0001168363,0.00005636755,0.0001504193],"domain_scores_gemma":[0.9989607,0.0003129145,0.0002089406,0.0001246235,0.00005415149,0.0003385756],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9827624,0.00626836,0.0001821611,0.0002524916,0.0004181123,0.00002105908,0.00004974136,0.0002044774,0.002456556,0.00009651905,0.0002635336,0.00702453],"study_design_scores_gemma":[0.9213977,0.0762592,0.0009425864,0.00001690573,0.0002293254,0.00001904275,0.00002294472,0.0002180121,0.0003300869,0.0001160806,0.0004340614,0.00001413897],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917654,0.00243214,0.0007494623,0.0003681759,0.0004419206,0.002130565,0.0006955446,0.0001217779,0.001294988],"genre_scores_gemma":[0.9871702,0.00270848,0.001714422,0.0006306375,0.0003844363,0.002328956,0.0007236354,0.00004535358,0.004293736],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006481716,"threshold_uncertainty_score":0.02168345,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09378879086140673,"score_gpt":0.4066840908216205,"score_spread":0.3128952999602138,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}